Akèy › Tit travay › Biomedical Engineer
Biomedical Engineer: Salè H-1B
124 aplikasyon kondisyon travay te itilize tit travay Biomedical Engineer. Salè baz medyàn ofri $92,331; mwatye mitan $80,019–$105,000.
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Soma Technology International, Inc. | 11 | $94,515 |
| VirtuSense Technologies, Inc. | 10 | $120,000 |
| Creative Biomart Inc. | 3 | $120,000 |
| 626 Opco, LLC | 3 | $105,000 |
| CHISON USA Inc. | 3 | — |
| Axle Informatics LLC | 3 | $115,000 |
| EverX USA, LLC | 3 | $127,500 |
| Guam Xray | 2 | $70,262 |
| NanoCellect Biomedical, Inc. | 2 | $101,884 |
| PPG Health, P.A. | 2 | $92,815 |
| Centers for Disease Control and Prevention | 2 | $60,282 |
| Document Solutions Group, Inc. | 2 | $59,328 |
| 3Key Consulting, Inc. | 2 | $88,400 |
| Kelly Services, Inc. | 2 | — |
| iRay Imaging LLC | 2 | $88,666 |
| 8Fold Mfg LLC | 2 | $63,971 |
| RyTek Medical, Inc. | 2 | — |
| iota Biosciences Inc. | 2 | $129,168 |
| Mount Sinai Hospital | 2 | $88,483 |
| Inexus Health, Inc. | 1 | — |
| Brain Electrophysiology Laboratory Company, LLC | 1 | — |
| Cellf-Bio, LLC | 1 | $66,600 |
| FWD Labs LLC | 1 | $67,600 |
| L&T Technology Services Limited | 1 | $198,000 |
| Advanced Solutions Network LLC | 1 | $85,000 |
| Citadel Information Services, Inc | 1 | $71,677 |
| Neuro42 Inc | 1 | $100,651 |
| CPBS Intermediate Holdings LLC | 1 | $59,259 |
| The Fountain Group, LLC | 1 | $114,400 |
| Rochal Technologies LLC | 1 | $82,500 |
| East Coast Orthotic & Prosthetic Corp | 1 | $80,000 |
| Frontier Bio Corporation | 1 | $90,688 |
| University of Utah | 1 | $86,849 |
| Angio8 Medical Corporation | 1 | — |
| Valira LLC | 1 | $91,354 |
| QuantCo, Inc. | 1 | $150,000 |
| Figur8, Inc. | 1 | $87,538 |
| Yugady Technologies & Services Inc | 1 | $88,442 |
| PhysCade, Inc. | 1 | $185,000 |
| Embecta Medical I LLC | 1 | $110,000 |
| Aequor Technologies, Inc. | 1 | $77,000 |
| Sar Tech LLC | 1 | $76,627 |
| Lilyli Future Foundation Inc | 1 | — |
| Vibrant America LLC | 1 | $75,275 |
| NanoRes LLC | 1 | — |
| Zymo Research Corporation | 1 | $101,675 |
| Magnetic Tides Inc. | 1 | $90,688 |
| Empire Bio Diagnostics Corp | 1 | $76,627 |
| Vazyme International LLC | 1 | $100,000 |
| HS Solutions Inc | 1 | $95,000 |
| Cyto Wave LLC | 1 | $70,000 |
| Aventusoft, LLC | 1 | $72,000 |
| Liberate Medical, LLC | 1 | $65,936 |
| iHealth Labs, Inc. | 1 | $75,300 |
| 12-15 Molecular Diagnostics, Inc | 1 | $79,227 |
| Incedo, Inc. | 1 | — |
| Innolcon Research, Inc. | 1 | $93,000 |
| Vanderbilt University Medical Center | 1 | $93,371 |
| Sanara MedTech Inc | 1 | $84,365 |
| IZiel Healthcare Inc | 1 | $105,000 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $79,893 |
| Nivo II (kalifye) | $94,515 |
| Nivo III (eksperyans) | $111,000 |
| Nivo IV (plen kompetans) | $155,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 28 | $92,084 |
| FY2024 | 33 | $90,688 |
| FY2025 | 25 | $94,515 |
| FY2026 | 21 | $92,331 |
Vil yo
- Bloomfield, CT11
- Peoria, IL10
- New York, NY5
- Shirley, NY3
- San Diego, CA3
- Alameda, CA3
- Exton, PA3
- Bellevue, WA3
- Vista, CA3
- Tamuning, GU2
- Erie, PA2
- Fort Worth, TX2
- Morgantown, WV2
- Malvern, PA2
- Cambridge, MA2
- San Antonio, TX2
- Baltimore, MD2
- Solon, OH2
- Palo Alto, CA2
- Addison, TX2
- Lebanon, NH2
- Irvine, CA2
- San Jose, CA2
- Bethesda, MD2
- Rockville, MD1
- Eugene, OR1
- Richmond, VA1
- Columbia, SC1
- Redmond, WA1
- Iselin, NJ1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).